Year: 2020
Type: article
Abstract: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting illness, coronavirus disease 2019 (COVID-19), has affected >9 million people globally, with >470,000 deaths. The highest number of cases and fatalities have occurred in the United States, with >120,000 deaths as of the end of June.1 In contrast to other common viral infections, COVID-19 presents unique challenges with high rates of hypoxemic respiratory failure, hyperinflammatory cytokine storm, coagulation abnormalities, and cardiac and renal dysfunction.
Source: CHEST Journal
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,300
Awards: Research and Mentorship in Medical Decision Making for Chronic Diseases of Older Adults, Research and Mentorship in Medical Decision Making in Diabetes, Sepsis Early Prediction and Subphenotype Illumination Study (SEPSIS), Merging Temporal Changes in Clinical Informatics, Transcriptomics, and Cytokine Profiles to Understand the Host Response to Bacteremia, Chicago Center for Diabetes Translation Research, Research training in respiratory biology
OpenAlex ID: W3043900303